Activation of ubiquitin-proteasome pathway is involved in skeletal muscle wasting in a rat model with biliary cirrhosis: Potential role of TNF-α

American Journal of Physiology - Endocrinology and Metabolism

Volumn 288, Issue 3 51-3, 2005, Pages

  Lin, Shih Yi ^a,d   Chen, Wen Yin ^a   Lee, Fa Yauh ^b   Huang, Ching Jang ^c   Sheu, Wayne Huey Herng ^a  

^a TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Atrophy; Cachexia; Catabolism; Liver; Tumor necrosis factor

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BETA ACTIN; BILIRUBIN; CALPAIN; CARRIER PROTEIN; CATHEPSIN B; CATHEPSIN D; CATHEPSIN L; MESSENGER RNA; MUSCLE PROTEIN; PROTEASOME; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN; UBIQUITIN CARRIER PROTEIN E2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIARY CIRRHOSIS; BODY WEIGHT; CACHEXIA; CATABOLISM; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; LIVER CIRRHOSIS; MALE; MUSCLE ATROPHY; MUSCLE MASS; NITROGEN BALANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CALPAIN; CATHEPSINS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; LIGATION; LIVER; LIVER CIRRHOSIS, BILIARY; MALE; METHYLHISTIDINES; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYOFIBRILS; NF-KAPPA B; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN SUBUNITS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; TYROSINE; UBIQUITIN; UBIQUITIN-CONJUGATING ENZYMES;

EID: 13844253851     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00186.2004     Document Type: Article

References (55)

1. Attaix D, Combaret L, Pouch MN, and Taillandier D. Regulation of proteolysis. Curr Opin Clin Nutr Metab Care 4: 45-49, 2001.
2. Barnes PJ and Karin M. Nuclear factor-κB: a pivotal transcription in chronic inflammation. N Engl J Med 336: 1066-1077, 1997.
3. Blonde-Cynober F, Plassart F, Rey C, Coudrary-Lucas C, Poupon R, Giboudeau J, and Cynober L. Assessment of the carbon tetrachloride-induced cirrhosis model for studies of nitrogen metabolism in chronic liver disease. Ann Nutr Metab 38: 238-248, 1994.
4. Bossola M, Muscaritoli M, Cotelli P, Bellantone R, Pacelli F, Busquets S, Argiles J, Lopez-Soriano FJ, Civello IM, Baccino FM, Fanelli FS, and Doglietto GB. Increased muscle ubiquitin mRNA levels in gastric cancer patients. Am J Physiol Regul Integr Comp Physiol 280: R1518-R1523, 2001.
5. Chai J, Wu Y, and Sheng Z. Role of ubiquitin-proteasome pathway in skeletal muscle wasting in rats with endotoxemia. Crit Care Med 31: 1802-1807, 2003.
6. Clark AS and Mitch WE. Comparison of protein synthesis and degradation in incubated and perfused muscle. Biochem J 212: 649-653, 1983.
7. Clements WDB, Halliday MI, McCaigue MD, Barclay RG, and Rolands BJ. Effects of extrahepatic obstructive jaundice on Kupffer clearance capacity. Arch Surg 128: 200-205, 1993.
8. Combarbet L, Tilignac T, Claustre A, Voisin L, Taillandier D, Obled C, Tanaka K, and Attaix D. Torbafylline (HWA 448) inhibits enhanced skeletal muscle ubiquitin-proteasome-dependent proteolysis in cancer and septic rats. Biochem J 361: 185-192, 2002.
9. Cook EB, Gove CD, Panos MZ, Williams R, and Preedy VR. Skeletal muscle protease activities are unaltered in cirrhotic rats but altered in response to ethanol and acetaldehyde in vitro. Alcohol Alcohol 30: 203-209, 1995.
10. Costelli P, Carbo N, Tessitori L, Bagby GJ, Lopex-Soriano FJ, Argiles JM, and Baccino FM. Tumor necrosis factor mediates changes in tissue protein turnover in a rat cancer cachexia model. J Clin Invest 92: 2783-2789, 1993.
11. Crawford DHG, Shepherd RW, Halliday JW, Cooksley GWGE, Golding SD, Cheng WSC, and Powell LW. Body composition in nonalcoholic cirrhosis: the effect of disease etiology and severity on nutrition compartments. Gastroenterology 106: 1611-1617, 1994.
12. Deviere J, Content J, Denys C, Vandenbussche P, Schanden L, Wybran J, and Dupont E. Excessive bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 11: 628-634, 1990.
13. DiCecco SR, Wieners EJ, Wiesner RH, Southorn PA, Plevak DJ, and Krom RAF. Assessment of nutritional status of patients with end-stage liver disease Undergoing liver transplantation. Mayo Clin Proc 64: 95-102, 1989.
14. Fernandez-Celemin L, Pasko N, Blomart V, and Thissen JP. Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor. Am J Physiol Endocrinol Metab 283: E1279-E1290, 2002.
15. Garcia-Martinez C, Agell N, Llovera M, Francisco J, Lopez-Soriano M, and Argiles JM. Tumor necrosis factor-α increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett 323: 211-214, 1993.
16. Garcia-Martinez C, Llovera M, Agell N, Francisco J, Lopez-Soriano M, and Argiles JM. Ubiquitin gene expression in skeletal muscle is increased by tumor necrosis factor-α. Biochem Biophys Res Commun 201: 682-686, 1994.
17. Garcia-Tsao G, Lee FY, Barden GE, Cartun M, and West AB. Bacterial translocation to mesenteric lymph node is increased in cirrhotic rats with ascites. Gastroenterology 108: 1835-1841, 1995.
18. Gayyan-Ramierz G, van de Casteele M, Rollier H, Fevery J, Vanderhoydone F, Verhoeven G, and Decramer M. Biliary cirrhosis induces type IIIx/b fiber atrophy in rat diaphragm and skeletal muscle, and decreases IGF-I mRNA in the liver but not in muscle. J Hepatol 29: 241-249, 1998.
19. Goodman MN. Tumor necrosis factor induces skeletal muscle breakdown in rat skeletal muscle. Am J Physiol Endocrinol Metab 260: E727-E730, 1991.
20. Gouma D, Roughneen PT, Kumar A, Moddy, and Rolands BJ. Change in nutritional status associated with obstructive jaundice and biliary drainage in rats. Am J Clin Nutr 44: 362-269, 1986.
21. Green JH, Bramley PN, and Losowsky MS. Are patients with primary biliary cirrhosis hypermetabolic? A comparison between patients before and after liver transplantation and controls. Hepatology 14: 464-472, 1991.
22. Guttridge DC, Mayo MW, Madrid LV, Wang CY, and Baldwing AS Jr. NF-κB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science 289: 2363-2366, 2000.
23. Harry D, Anand R, Holi S, Davies S, Marley R, Fernado B, Goodier D, and Moore K. Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic rats. Hepatology 30: 1198-1205, 1999.
24. Hasselgren PO and Fischer JE. Muscle cachexia: current concepts of intracellular mechanisms and molecular regulation. Ann Surg 233: 9-17, 2001.
25. Heller J, Sogni P, Barriere E, Tazi KA, Chauvelot-Moachon L, Guimont MC, Bories PN, Poirel O, Moreau R, and Lebrec D. Effects of lipopolysaccharide on TNF-α production, hepatic NOS2 activity, and hepatic toxicity in rats with cirrhosis. J Hepatol 33: 376-381, 2000.
26. Hershko A and Ciechanover A. The ubiquitin system. Annu Rev Biochem 67: 425-479, 1998.
27. 14k mRNA in skeletal muscle. Am J Physiol 45: R468-R473, 1999.
28. Italian Multicentre Cooperative Project on Nutrition in Liver Cirrhosis. Nutrition status in cirrhosis. J Hepatol 21: 317-325, 1994.
29. Kountouras J, Billing BH, and Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rats. Br J Exp Pathol 65: 305-301, 1984.
30. Kumar A and Boriek A. Mechanical stress activates the nuclear factor-kappa B pathway in skeletal fibers: a possible role in Duchenne muscular dystrophy. FASEB J 17: 386-396, 2003.
31. Lander KJ, Carligiur MA, and Guttridge DC. Tumor necrosis factor-regulated biphasic activation of NF-κB is required for cytokine-induced loss of skeletal muscle gene production. J Biol Chem 278: 2294-2303, 2003.
32. Langen RCJ, Schols AMWJ, Kelders MCJM, Wouters EFM, and Jassen-Heininger YMW. Inflammatory cytokines inhibit myogenic differentiation through activation of nuclear factor-κB. FASEB J 15: 1169-1180, 2001.
33. Lee FY, Wang SS, Yang MCY, Tsai YT, Wu SL, Lu WI, Chan CY, and Lee SD. Role of endotoxemia in hyperdynamic circulation in rats with extrahepatic or intrahepatic portal hypertension. J Gastroenterol Hepatol 11: 152-158, 1996.
34. 20k. FASEB J 17: 1048-1057, 2003.
35. Li YP and Reid MB. NF-κB mediates the protein loss induced by TNF-alpha in differentiated myotubles. Am J Physiol Regul Integr Comp Physiol 279: R1165-R1170, 2000.
36. Lin SY, Wang YY, and Sheu WHH. Increased serum leptin concentrations correlate with soluble tumor necrosis factor receptors levels in patients with liver cirrhosis. Clin Endocrinol (Oxf) 57: 805-811, 2002.
37. Liu H, Ma Z, and Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in the bile-duct ligated rats. Gastroenterology 118: 937-944, 2000.
38. Llovera M, Garcia-Martinez C, Agell N, Francisco J, Lopez-Soriano M, and Argiles JM. TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. Biochem Biophys Res Commun 230: 238-241, 1997.
39. Llovera M, Lopez-Soriano FJ, and Argiles JM. Effects of tumor necrosis factor-α on muscle-protein turnover in female Wistar rats. J Natl Cancer Inst 85: 1334-1339, 1992.
40. Lundblad R, Nesland JM, and Giercksky KE. Granulocyte colon stimulating factor improves survival rate and reduces concentrations of bacteria, endotoxin, tumor necrosis factor, and endothelin-1 in fulminant intra-abdominal sepsis in rats. Crit Care Med 24: 820-826, 1996.
41. Mitch WE and Golderg AL. Mechanisms of muscle wasting: the role of ubiquitin-proteasome system. N Engl J Med 335: 1897-1905, 1996.
42. Mitch WE, Medina R, Greber S, May RC, England BK, Price SR, Bailey JL, and Goldberg AL. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine-triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest 93: 2127-2133, 1994.
43. Muller MJ. Malnutrition in cirrhosis. J Hepatol 23, Suppl 1: 31-35, 1995.
44. Pickering WP, Price SR, Bircher G, Marinovic AC, Mitch WE, and Walls J. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int 61: 1286-1292, 2002.
45. Scott-Conner CEH and Grogan JB. The pathophysiology of biliary obstruction and its effect on phagocytic and immune function. J Surg Res 57: 293-299, 1994.
46. Sheron N, Lau J, Daniles H, Goka J, Eddleston A, Alexander GJ, and William R. Increased production of tumor necrosis factor in chronic hepatitis B virus infection. J Hepatol 12: 241-245, 1991.
47. Temparis S, Asensi M, Taillandier D, Aurousseau E, Larbaud D, Obled A, Bechet D, Ferrara M, Estrela JM, and Attaix D. Increased ATP- ubiquitin-dependent proteolysis in skeletal muscle of tumor-bearing rats. Cancer Res 54: 5568-5573, 1994.
48. Tessari P. Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care 6: 79-85, 2003.
49. Tiao G, Gagan JM, Samuels N, James JH, Hudson L, Lieberman M, Fisher JE, and Hasselgren PO. Sepsis stimulates non-lysosomal energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J Clin Invest 94: 2255-2264, 1994.
50. Tiao G, Hobler S, Wang JJ, Meyer TA, Luchette FA, Fischer JE, and Hasselgren PO. Sepsis is associated with increased mRNAs of the ubiquitin-proteasome proteolytic pathway in human skeletal muscle. J Clin Invest 99: 163-168, 1997.
51. Tilg H, Wilmer A, Vogel W, Herold M, Nolchen B, Judmaier G, and Huber C. Serum levels of cytokines in chronic liver diseases. Gastroenterology 103: 264-274, 1992.
52. Tracey KJ and Cerami A. Tumor necrosis factor: a pleitropic cytokine and therapeutic target. Annu Rev Med 45: 491-503, 1994.
53. Weber FJ, Macechko PL Jr, Kelson SR, Karajiannis E, and Hassen MO. Increased muscle protein catabolism by carbon tetrachloride hepatic injury in rats. Gastroenterology 102: 1700-1706, 1992.
54. Wing SS, Hass AL, and Goldberg AL. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. Biochem J 307: 639-645, 1995.
55. Zoli M, Marchesini G, Dondi C, Bianchi GP, and Pisi E. Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting. Clin Sci (Lond) 62: 683-686, 1982.